Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10888605 GLP-1 compositions and uses thereof

Patent 10888605 was granted and assigned to Novo Nordisk on January, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+230 characters)
Article

Patent abstract

The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.01% (w/w) phenol, their preparation, kits comprising such compositions as well as uses thereof.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits on 13 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11752198 GLP-1 compositions and uses thereof
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1088860500
Edits on 3 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novo Nordisk
Novo Nordisk
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
108886050
Date of Patent
January 12, 2021
0
Patent Application Number
167746660
Date Filed
January 28, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=108886050
Patent Citations Received
‌
US Patent 11478533 Semaglutide for use in medicine
0
Patent Primary Examiner
‌
Sudhakar Katakam
0
Edits on 28 Oct, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11478533 Semaglutide for use in medicine
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Novo Nordisk
Novo Nordisk
0
Current Assignee
Novo Nordisk
Novo Nordisk
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
108886050
Date of Patent
January 12, 2021
0
Patent Application Number
167746660
Date Filed
January 28, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=108886050
Patent Primary Examiner
‌
Sudhakar Katakam
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10888605
Edits on 9 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Feb, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10888605 GLP-1 compositions and uses thereof

Infobox
Is a
Patent
Patent
Patent applicant
Novo Nordisk
Novo Nordisk
Current assignee
Novo Nordisk
Novo Nordisk
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10888605
Date of patent
January 12, 2021
Patent application number
16774666
Date Filed
January 28, 2020
Patent primary examiner
‌
Sudhakar Katakam

Find more entities like US Patent 10888605 GLP-1 compositions and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo